Showing results (31-40 of 518) with videos related to
Sort By:
Pageof 52
Immunologic Research|January 10, 2004
CTLA-4 and tolerance: the biochemical point of viewShunsuke Chikuma, Jeffrey A BluestoneProceedings of the National Academy of Sciences of the United States of America|August 24, 2004
Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cellsJeffrey A Bluestone, Qizhi TangCancer Investigation|January 1, 1983
Suppression of the immune response in tumor-bearing mice. III. Induction of functionally suppressive antigen-driven macrophagesJ A Bluestone, C LopezJournal of the National Cancer Institute|November 1, 1979
Suppression of the immune response in tumor-bearing mice. I. Response to virus-producing tumor cells and non-virus-producing tumor cellsJ A Bluestone, C LopezThe Journal of Clinical Investigation|December 7, 2007
B cell depletion: a novel therapy for autoimmune diabetes?Hélène Bour-Jordan, Jeffrey A BluestoneImmunological Reviews|May 12, 2009
Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cellsHélène Bour-Jordan, Jeffrey A BluestoneScience Translational Medicine|August 12, 2011
Type 1 diabetes immunotherapy: is the glass half empty or half full?Kevan C Herold, Jeffrey A BluestoneNephron|January 1, 1985
Defective renal prostaglandin synthesis in hypertensive patients with morbid obesityE T Zawada, L Dornfeld, M Johnson, et al.Current Opinion in Immunology|August 17, 2002
Immunotherapy of insulin-dependent diabetes mellitusEmma L Masteller, Jeffrey A BluestoneNature Reviews. Immunology|March 27, 2003
Natural versus adaptive regulatory T cellsJeffrey A Bluestone, Abul K AbbasPageof 52